UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 941

Sortiert nach

The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial

Journal of diabetes and its complications, 2011-11, Vol.25 (6), p.355-361

2011

Link zum Volltext

Verfügbarkeit prüfen

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

The New England journal of medicine, 2019-08, Vol.381 (7), p.603-613

2019

Link zum Volltext

Verfügbarkeit prüfen

Oral Glucose Tolerance Test Measures of First-phase Insulin Response and Their Predictive Ability for Type 1 Diabetes

The journal of clinical endocrinology and metabolism, 2022-07, Vol.107 (8), p.e3273-e3280

2022

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials

The Lancet (British edition), 2013-06, Vol.381 (9881), p.1905-1915

2013

Link zum Volltext

Verfügbarkeit prüfen

B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year Results

Diabetes care, 2014-02, Vol.37 (2), p.453-459

2014

Link zum Volltext

Verfügbarkeit prüfen

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

The New England journal of medicine, 2009-11, Vol.361 (22), p.2143-2152

2009

Link zum Volltext

Verfügbarkeit prüfen

Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment

Diabetes care, 2014-04, Vol.37 (4), p.1069-1075

2014

Link zum Volltext

Verfügbarkeit prüfen

The Pathological Evolution of Glucose Response Curves During the Progression to Type 1 Diabetes in the TrialNet Pathway to Prevention Study

Diabetes care, 2020-11, Vol.43 (11), p.2668-2674

2020

Link zum Volltext

Verfügbarkeit prüfen

The shape of the glucose concentration curve during an oral glucose tolerance test predicts risk for type 1 diabetes

Diabetologia, 2018-01, Vol.61 (1), p.84-92

2018

Link zum Volltext

Verfügbarkeit prüfen

Blood pressure and pulse pressure effects on renal outcomes in the Veterans Affairs Diabetes Trial (VADT)

Diabetes care, 2014-10, Vol.37 (10), p.2782-2788

2014

Link zum Volltext

Verfügbarkeit prüfen

Continuous subcutaneous Insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: A randomized, parallel-group, 24-week study

Diabetes care, 2003-09, Vol.26 (9), p.2598-2603

2003

Link zum Volltext

Verfügbarkeit prüfen

The Effect of DPT-1 Intravenous Insulin Infusion and Daily Subcutaneous Insulin on Endogenous Insulin Secretion and Postprandial Glucose Tolerance

Diabetes care, 2015-05, Vol.38 (5), p.891-896

2015

Link zum Volltext

Verfügbarkeit prüfen

Adaptation of β-Cell and Endothelial Function to Carbohydrate Loading: Influence of Insulin Resistance

Diabetes (New York, N.Y.), 2015-07, Vol.64 (7), p.2550-2559

2015

Link zum Volltext

Verfügbarkeit prüfen

Adaptation of [Beta]-Cell and Endothelial Function to Carbohydrate Loading: Influence of Insulin Resistance

Diabetes (New York, N.Y.), 2015-07, Vol.64 (7), p.2550

2015

Link zum Volltext

Verfügbarkeit prüfen

Perioperative management of diabetes

American family physician, 2003-01, Vol.67 (1), p.93-100

Marks, Jennifer B

2003

Link zum Volltext

Verfügbarkeit prüfen

Effect of angiotensin receptor blockade on insulin sensitivity and endothelial function in abdominally obese hypertensive patients with impaired fasting glucose

Clinical science (1979), 2012-02, Vol.122 (4), p.193

2012

Link zum Volltext

Verfügbarkeit prüfen

Advances in Obesity Treatment: Clinical Highlights from the NAASO 2003 Annual Meeting

Clinical diabetes, 2004-12, Vol.22 (1), p.23-26

Marks, Jennifer B.

2004

Link zum Volltext

Verfügbarkeit prüfen

Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals

Science translational medicine, 2021-03, Vol.13 (583)

2021

Link zum Volltext

Verfügbarkeit prüfen

In Pursuit of Type 1 Diabetes Prevention

Clinical diabetes, 2002-10, Vol.20 (4), p.168-169

Marks, Jennifer B.

2002

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular risk in diabetes: A brief review

Journal of Diabetes and Its Complications, 2000-03, Vol.14 (2), p.108-115

2000

Link zum Volltext

Verfügbarkeit prüfen

Metabolic Syndrome: To Be or Not To Be?

Clinical diabetes, 2006-12, Vol.24 (1), p.3-4

Marks, Jennifer B

2006

Link zum Volltext

Verfügbarkeit prüfen

A Look Back... and Forward

Clinical diabetes, 2006-04, Vol.24 (2), p.51-53

Marks, Jennifer B

2006

Link zum Volltext

Verfügbarkeit prüfen

The Forgotten Complication

Clinical diabetes, 2005-01, Vol.23 (1), p.3-4

Marks, Jennifer B.

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 941

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(794)
Mit Volltextzugriff
(782)

Publikationsform

Sprache

Englisch
(941)
Japanisch
(152)
Norwegisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The New England Journal Of Medicine
(41)
Diabetes Care
(29)
Pediatrics
(29)
Nature
(27)
Nature Genetics
(25)
New England Journal Of Medicine
(22)
Plos One
(19)
Clinical Diabetes
(18)
Nature Communications
(14)
Neurology
(12)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

Oral Glucose Tolerance Test Measures of First-phase Insulin Response and Their Predictive Ability for Type 1 Diabetes

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials

B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year Results

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment

The Pathological Evolution of Glucose Response Curves During the Progression to Type 1 Diabetes in the TrialNet Pathway to Prevention Study

The shape of the glucose concentration curve during an oral glucose tolerance test predicts risk for type 1 diabetes

Blood pressure and pulse pressure effects on renal outcomes in the Veterans Affairs Diabetes Trial (VADT)

Continuous subcutaneous Insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: A randomized, parallel-group, 24-week study

The Effect of DPT-1 Intravenous Insulin Infusion and Daily Subcutaneous Insulin on Endogenous Insulin Secretion and Postprandial Glucose Tolerance

Adaptation of β-Cell and Endothelial Function to Carbohydrate Loading: Influence of Insulin Resistance

Adaptation of [Beta]-Cell and Endothelial Function to Carbohydrate Loading: Influence of Insulin Resistance

Perioperative management of diabetes

Effect of angiotensin receptor blockade on insulin sensitivity and endothelial function in abdominally obese hypertensive patients with impaired fasting glucose

Advances in Obesity Treatment: Clinical Highlights from the NAASO 2003 Annual Meeting

Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals

In Pursuit of Type 1 Diabetes Prevention

Cardiovascular risk in diabetes: A brief review

Metabolic Syndrome: To Be or Not To Be?

A Look Back... and Forward

The Forgotten Complication

Suchergebnisse filtern